- $2.22bn
- $2.45bn
- $727.33m
U.S. STOCKS ON THE MOVE-Customers Bancorp, Forgent Power Solutions, Nvidia
U.S. STOCKS ON THE MOVE-Dollar Tree, Micron, Customers Bancorp
U.S. STOCKS ON THE MOVE-Intuit, Acumen, Circle,
U.S. STOCKS ON THE MOVE-Sable Offshore, Nebius, Upstart
Brief: Neogenomics Inc - Pantracer Lbx Test Receives Medicare Coverage Under CMS Moldx Program
NeoGenomics rises as Medicare covers new cancer blood test
Brief: Neogenomics Reports Fourth Quarter And Full Year 2025 Results
NeoGenomics Q4 revenue rises, adjusted EPS beats estimates
NeoGenomics prelim Q4 revenue slightly beats estimates, names insider as CFO
Life sciences and contract research stocks navigate turbulence in 2025
Brief: Neogenomics Appoints Diagnostics And Lab Services Industry Veteran John P. “Jack” Kenny To Its Board Of Directors
U.S. STOCKS ON THE MOVE-Robinhood Markets, Cannabis stocks, Hyatt Hotels
U.S. STOCKS ON THE MOVE-Spotify, Robinhood Markets, Cannabis stocks
U.S. STOCKS ON THE MOVE-Jabil, Texas Pacific Land, Texas Roadhouse
Jefferies updates ratings on life sciences firms for 2026
Brief: Neogenomics Announces That Natera Has Voluntarily Withdrawn Its Appeal In Ongoing RaDaR Patent Litigation
Cancer diagnostics company NeoGenomics beats Q3 estimates on clinical revenue growth
U.S. STOCKS ON THE MOVE-SentinelOne, Autodesk, Dollar Tree
NeoGenomics rises after winning patent infringement lawsuit against Natera